Hui Cao

Title: Innovations by Hui Cao in Breast Cancer Treatment

Introduction

Hui Cao is an accomplished inventor based in Cambridge, MA (US). She has made significant contributions to the field of cancer research, particularly in monitoring endocrine therapy for breast cancer. Her innovative work has the potential to improve treatment outcomes for patients.

Latest Patents

Hui Cao holds a patent titled "Panel of ER regulated genes for use in monitoring endocrine therapy in breast cancer." This patent describes a method for using a panel of estrogen receptor (ER) regulated genes to monitor the response of individuals with cancer to treatment with amcenestrant. The method involves determining a first ER activity score from a sample taken before treatment and a second score after treatment. A decrease in the second score compared to the first is predictive of the drug's effectiveness.

Career Highlights

Hui Cao is currently employed at Sanofi, a global biopharmaceutical company. Her work at Sanofi focuses on developing innovative solutions for cancer treatment. She has demonstrated a strong commitment to advancing medical research and improving patient care.

Collaborations

Hui collaborates with talented colleagues, including Monsif Bouaboula and Joon Sang Lee. These collaborations enhance her research efforts and contribute to the development of effective cancer therapies.

Conclusion

Hui Cao's innovative contributions to breast cancer treatment through her patent and work at Sanofi highlight her dedication to improving patient outcomes. Her research is paving the way for more effective monitoring and treatment strategies in oncology.